Citation Tools

Original research
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma

Download to a citation manager

Cite this article as:
Borgers JSW, van Wesemael TJ, Gelderman KA, et al
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma